MedTrace Logo

Assessment of Sensory Gating, Attention, and Executive Control in Breast Cancer

NCT03619083 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 187

Last updated 2026-03-10

No results posted yet for this study

Summary

This study is being done to find out if a new series of evaluations called the SAE (Sensory-Attention-Executive) Battery can help researchers learn more about how cancer treatment does or does not change the way the brain processes/filters information, emotions, attention span, and behavior by comparing the results of the SAE Battery with traditional evaluations like questionnaires.

Conditions

Interventions

OTHER

SAE battery

The SAE battery yields 12 variables.

BEHAVIORAL

Assessments

Assessments of their neurocognitive performance will be assessed longitudinally, at 4 time points: prior to adjuvant treatment (post-surgery); 1 month (with a +4 week window) post-chemotherapy; and again at the 12 and 24 months (with a +4 week window) post-treatment time points. These assessment time points are denoted as T1 though T4, respectively. The assessment schedule for the HC and CT- groups will be yoked against that of the CT+ cohort.

Sponsors & Collaborators

Principal Investigators

  • James Root, PhD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-13
Primary Completion
2027-07-31
Completion
2027-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03619083 on ClinicalTrials.gov